Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms

Keenan, D. Barry; Mastrototaro, John J.; Zisser, Howard; Cooper, Kenneth A.; Raghavendhar, Gautham; Lee, Scott W.; Yusi, Jonathan; Bailey, Timothy S.; Brazg, Ronald; Shah, Rajiv

doi:10.1089/dia.2011.0199

Cited by 88 publications

(65 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It should also be noted that the Enlite sensors are also used with the Paradigm Veo Pump (Medtronic MiniMed, Northridge, CA), and that the Veo's calibration algorithm is reported to be different from that of the Guardian REAL-Time. 25 However, the Guardian is a stand-alone CGM system, i.e., it can be used by people with diabetes who do not wear an insulin pump. The Guardian is also used with Enlite sensors; at least in Germany, Enlite sensors are sold to be used with the Guardian.…”

Section: Discussionmentioning

confidence: 99%

Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel

Freckmann

Pleus

Link

et al. 2013

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel

Freckmann

Pleus

Link

et al. 2013

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

“…Continuous glucose monitoring, when used the majority of time, profits in improving diabetes outcomes and reducing caregivers' worry about hypoglycemia [12,13]. The glucometer Contour ® Plus Link 2.4 connected with Enlite sensor is a manageable and comfortable system which was confirmed in some clinical trials [14,15]. Its accuracy and better coherence between blood glucose measured by sensor and glucose meter helped patients to trust the new technology and to significantly reduce the frequency of pricking fingers in order to check glucose level.…”

Section: Appendix 2 Authorial Questionnairementioning

confidence: 97%

Evaluation of the quality of life and satisfaction with the therapy in patients with type 1 diabetes — is Medtronic MiniMed 640G system able to improve it? Preliminary insights

Tabor

Gawel

Goik

et al. 2017

Clinical Diabetology

View full text Add to dashboard Cite

“…The high glucose alert was discontinued once patients left the laboratory after the experimental trials. Sensors were placed in the posterolateral abdominal region to minimize the physiological time lag between blood and interstitial glucose (24). Insertion site was replicated across visits.…”

Section: Continuous Glucose Monitoringmentioning

confidence: 99%

A Low–Glycemic Index Meal and Bedtime Snack Prevents Postprandial Hyperglycemia and Associated Rises in Inflammatory Markers, Providing Protection From Early but Not Late Nocturnal Hypoglycemia Following Evening Exercise in Type 1 Diabetes

et al. 2014

View full text Add to dashboard Cite

OBJECTIVETo examine the influence of the glycemic index (GI) of foods consumed after evening exercise on postprandial glycemia, metabolic and inflammatory markers, and nocturnal glycemic control in type 1 diabetes. RESEARCH DESIGN AND METHODSOn two evenings (∼1700 h), 10 male patients (27 6 5 years of age, HbA 1c 6.7 6 0.7% [49.9 6 8.1 mmol/mol]) were administered a 25% rapid-acting insulin dose with a carbohydrate bolus 60 min before 45 min of treadmill running. At 60 min postexercise, patients were administered a 50% rapid-acting insulin dose with one of two isoenergetic meals (1.0 g carbohdyrate/kg body mass [BM]) matched for macronutrient content but of either low GI (LGI) or high GI (HGI). At 180 min postmeal, the LGI group ingested an LGI snack and the HGI group an HGI snack (0.4 g carbohdyrate/kg BM) before returning home (∼2300 h). Interval samples were analyzed for blood glucose and lactate; plasma glucagon, epinephrine, interleukin-6 (IL-6), and tumor necrosis factor-a (TNF-a); and serum insulin, cortisol, nonesterified fatty acid, and b-hydroxybutyrate concentrations. Interstitial glucose was recorded for 20 h postlaboratory attendance through continuous glucose monitoring. RESULTSFollowing the postexercise meal, an HGI snack induced hyperglycemia in all patients (mean 6 SD glucose 13.5 6 3.3 mmol/L) and marked increases in TNF-a and IL-6, whereas relative euglycemia was maintained with an LGI snack (7.7 6 2.5 mmol/L, P < 0.001) without inflammatory cytokine elevation. Both meal types protected all patients from early hypoglycemia. Overnight glycemia was comparable, with a similar incidence of nocturnal hypoglycemia (n = 5 for both HGI and LGI). CONCLUSIONS ConsumingLGI food with a reduced rapid-acting insulin dose following evening exercise prevents postprandial hyperglycemia and inflammation and provides hypoglycemia protection for ∼8 h postexercise; however, the risk of late nocturnal hypoglycemia remains.

show abstract

Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms

Abstract: The Enlite sensor accurately measures glucose when compared with gold standard laboratory measurements over its 6-day use. Sensors placed in the buttocks region exhibited greater time lags than sensors placed in the abdomen.

Cited by 88 publications

References 21 publications

Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel

Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel

Evaluation of the quality of life and satisfaction with the therapy in patients with type 1 diabetes — is Medtronic MiniMed 640G system able to improve it? Preliminary insights

A Low–Glycemic Index Meal and Bedtime Snack Prevents Postprandial Hyperglycemia and Associated Rises in Inflammatory Markers, Providing Protection From Early but Not Late Nocturnal Hypoglycemia Following Evening Exercise in Type 1 Diabetes

Contact Info

Product

Resources

About